Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo. Try Elite Free for 7 Days
Last Close
50.43
Sep 01 • 3:59 PM ET Dollar change+0.04 Percentage change(0.08%)
Aftermarket Close
50.00
Aftermarket • 7:30 PM ET Dollar change-0.43 Percentage change(-0.85%)
Index
RUT
Market Cap
4.39B
Enterprise Value
4.25B
Income
-118.37M
Sales
212.07M
Book/sh
3.23
Cash/sh
1.87
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
843
IPO
Aug 08, 2025
P/E
-
Forward P/E
-
PEG
-
P/S
20.68
P/B
15.63
P/C
26.98
P/FCF
-
EV/EBITDA
-
EV/Sales
20.04
Quick Ratio
4.87
Current Ratio
4.87
Debt/Eq
0.10
LT Debt/Eq
0.07
Option/Short
Yes / Yes
EPS (ttm)
-1.40
EPS next Y
-0.26
EPS next Q
-0.10
EPS this Y
74.31%
EPS next Y
36.64%
EPS next 5Y
-
EPS past 3/5Y
5.20% -
Sales past 3/5Y
42.10% -
EPS Y/Y TTM
-
Sales Y/Y TTM
-
EPS Q/Q
-65.19%
Sales Q/Q
47.57%
Insider Own
25.82%
Insider Trans
-9.71%
Inst Own
82.68%
Inst Trans
33.35%
ROA
-46.99%
ROE
-154.23%
ROIC
-39.45%
Gross Margin
80.08%
Oper. Margin
-34.31%
Profit Margin
-55.82%
SMA20
23.00%
SMA50
52.66%
SMA200
70.29%
Trades
Shs Outstand
86.72M
Shs Float
64.50M
52W High
51.19 -1.48%
52W Low
20.13 150.52%
Volatility
4.60% 5.91%
ATR (14)
2.41
RSI (14)
80.94
Beta
2.71
Rel Volume
0.94
Avg Volume
1.80M
Volume
1,678,319
Perf Week
1.08%
Perf Month
88.45%
Perf Quarter
70.66%
Perf Half Y
111.27%
Perf YTD
73.00%
Perf Year
60.10%
Perf 3Y
-
Perf 5Y
-
Perf 10Y
-
Prev Close
50.39
Price
50.43
Change %
0.08%
Date Action Analyst Rating Change Price Target Change
Jul-31-26Initiated Robert W. Baird Outperform $34
May-04-26Initiated William Blair Outperform
Jan-28-26Initiated Wells Fargo Overweight $38
Sep-02-25Initiated Stifel Buy $35
Sep-02-25Initiated Piper Sandler Overweight $38
Sep-02-25Initiated Morgan Stanley Equal-Weight $35
Sep-02-25Initiated JP Morgan Overweight $36
Sep-02-25Initiated Canaccord Genuity Buy $35
Aug-28-26 02:48AM
Aug-27-26 04:01PM
Aug-14-26 10:11AM
08:30AM
01:02AM
04:28PM Loading…
Aug-13-26 04:28PM
04:01PM
Aug-12-26 09:21AM
Jul-31-26 09:46AM
Jul-23-26 04:01PM
Jul-21-26 08:22AM
Jul-09-26 08:00AM
Jun-16-26 09:11AM
May-15-26 01:02AM
May-14-26 04:28PM
04:01PM Loading…
04:01PM
May-13-26 09:16AM
Apr-23-26 04:05PM
Apr-13-26 08:30AM
Mar-27-26 09:30AM
Mar-18-26 11:00PM
04:22PM
04:01PM
Mar-17-26 09:18AM
Mar-16-26 08:00AM
Feb-25-26 01:26AM
Feb-18-26 04:05PM
Feb-13-26 04:21PM
Feb-12-26 08:00AM
Jan-29-26 09:41AM
09:39AM Loading…
Jan-28-26 09:39AM
Jan-06-26 08:00AM
Jan-05-26 04:05PM
Dec-23-25 11:53PM
Dec-18-25 07:42PM
04:05PM
Dec-12-25 09:49AM
Dec-11-25 03:10AM
Nov-19-25 04:33PM
Nov-12-25 04:22PM
04:01PM
Nov-09-25 01:30PM
Nov-04-25 07:06AM
Nov-03-25 08:00AM
Oct-23-25 04:05PM
Oct-22-25 08:00AM
Sep-29-25 08:07AM
Sep-23-25 06:55PM
Sep-22-25 04:05PM
Sep-19-25 05:28PM
Sep-11-25 01:00AM
Sep-06-25 06:35AM
Sep-04-25 10:20AM
Sep-03-25 04:54PM
04:54PM
09:16AM
Sep-02-25 09:45AM
Aug-27-25 04:24PM
Aug-18-25 01:16PM
Aug-11-25 04:30PM
Aug-09-25 09:53AM
Aug-08-25 01:40PM
Jul-22-25 06:28PM
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.
PresidentMr. John C.M. Farquhar
Chief Financial OfficerMr. Vikram Verghese C.F.A.
M.D.Dr. Campbell D.K. Rogers FACC
Co-FounderDr. John Henry Stevens M.D.
Senior Vice President of OperationsMs. Kathleen Carey
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Farquhar John C.M.Chief Executive OfficerAug 21 '26Sale50.0027,2301,361,500360,814Aug 25 05:32 PM
Farquhar John C.M.OfficerAug 21 '26Proposed Sale50.0027,2301,361,500Aug 21 01:07 PM
Farquhar John C.M.Chief Executive OfficerAug 18 '26Sale45.0032,6761,470,420388,044Aug 20 05:56 PM
Rogers CampbellChief Medical OfficerAug 17 '26Option Exercise19.009,219175,16195,678Aug 19 09:04 PM
Rogers CampbellChief Medical OfficerAug 17 '26Sale41.239,219380,09986,459Aug 19 09:04 PM
Farquhar John C.M.Chief Executive OfficerAug 14 '26Sale39.0615,560607,774420,720Aug 18 06:38 PM
Farquhar John C.M.OfficerAug 18 '26Proposed Sale45.0032,6761,470,420Aug 18 05:11 PM
Rogers CampbellOfficerAug 17 '26Proposed Sale41.239,219380,099Aug 17 12:51 PM
Cohen Arthur BruceAffiliate of HCPCIV 1 LLCAug 14 '26Proposed Sale42.17200,0008,434,000Aug 14 04:58 PM
Healey Joseph PatrickAffiliate of HCPCIV 1 LLCAug 14 '26Proposed Sale41.50150,0006,225,000Aug 14 03:29 PM
Farquhar John C.M.OfficerAug 14 '26Proposed Sale39.0615,560607,774Aug 14 12:35 PM
Farquhar John C.M.Chief Executive OfficerAug 10 '26Sale28.3122,562638,730436,280Aug 12 05:07 PM
Farquhar John C.M.OfficerAug 10 '26Proposed Sale28.3122,562638,730Aug 10 01:00 PM
Farquhar John C.M.Chief Executive OfficerJul 30 '26Option Exercise5.0631,220158,014466,593Jul 31 06:16 PM
Verghese VikramChief Financial OfficerJul 27 '26Option Exercise2.2222,52249,999255,898Jul 28 05:47 PM
Lightcap Jeffrey CDirectorJul 24 '26Option Exercise19.0047,420900,980293,681Jul 28 05:42 PM
BARABE TIMOTHY CDirectorJul 22 '26Option Exercise19.003,71070,490188,231Jul 24 06:40 PM
Verghese VikramChief Financial OfficerJul 21 '26Option Exercise2.2222,52249,999233,376Jul 23 05:56 PM
BARABE TIMOTHY CDirectorJul 17 '26Option Exercise19.005,00095,000184,521Jul 20 06:18 PM
Rogers CampbellChief Medical OfficerJul 15 '26Option Exercise19.009,219175,16197,950Jul 17 05:54 PM
Rogers CampbellChief Medical OfficerJul 15 '26Sale25.729,219237,11388,731Jul 17 05:54 PM
Rogers CampbellOfficerJul 15 '26Proposed Sale25.729,219237,113Jul 15 10:05 AM
Farquhar John C.M.Chief Executive OfficerJul 10 '26Sale27.7522,562626,096435,373Jul 13 08:25 PM
WELDON WILLIAM CDirectorJul 08 '26Option Exercise8.3351,369427,904243,931Jul 10 05:50 PM
Farquhar John C.M.OfficerJul 10 '26Proposed Sale27.7522,562626,096Jul 10 09:43 AM
Farquhar John C.M.Chief Executive OfficerJun 24 '26Sale35.0038,9001,361,500457,935Jun 26 06:08 PM
Farquhar John C.M.OfficerJun 24 '26Proposed Sale35.0038,9001,361,500Jun 24 10:38 AM
Rogers CampbellChief Medical OfficerJun 15 '26Option Exercise2.2210,00022,20088,731Jun 17 05:39 PM
Farquhar John C.M.Chief Executive OfficerJun 10 '26Sale28.5022,562643,017496,835Jun 12 06:55 PM
Farquhar John C.M.OfficerJun 10 '26Proposed Sale28.5022,562643,017Jun 10 10:47 AM
Rogers CampbellChief Medical OfficerMay 18 '26Option Exercise19.009,219175,16187,950May 20 05:55 PM
Rogers CampbellChief Medical OfficerMay 18 '26Sale28.349,219261,26678,731May 20 05:55 PM
Rogers CampbellOfficerMay 18 '26Proposed Sale28.349,219261,266May 18 11:48 AM
Farquhar John C.M.Chief Executive OfficerMay 11 '26Sale29.1222,562657,005519,397May 13 06:23 PM
Farquhar John C.M.OfficerMay 11 '26Proposed Sale29.1222,562657,005May 11 10:20 AM
Bain Capital Life Sciences Inv10% OwnerApr 30 '26Sale29.23948,75727,733,6448,448,158Apr 30 08:46 PM
Bain Capital Life Sciences Inv10% OwnerApr 29 '26Sale29.37797,13323,411,7969,396,915Apr 30 08:46 PM
Bain Capital Life Sciences Inv10% OwnerApr 28 '26Sale30.51254,1107,752,89610,194,048Apr 30 08:46 PM
Farquhar John C.M.Chief Executive OfficerApr 10 '26Sale26.7222,562602,857549,163Apr 14 05:53 PM
Farquhar John C.M.OfficerApr 10 '26Proposed Sale26.7222,562602,857Apr 10 11:03 AM
Rogers CampbellChief Medical OfficerApr 01 '26Option Exercise2.2567,017150,556145,535Apr 03 06:15 PM
Rogers CampbellChief Medical OfficerApr 01 '26Sale24.6464,5331,590,09381,002Apr 03 06:15 PM
Rogers CampbellOfficerApr 01 '26Proposed Sale24.6464,5331,589,935Apr 01 04:23 PM
Rogers CampbellChief Medical OfficerMar 19 '26Option Exercise2.2267,017148,778143,051Mar 23 06:33 PM
Rogers CampbellChief Medical OfficerMar 19 '26Sale25.6964,5331,658,03378,518Mar 23 06:33 PM
Farquhar John C.M.Chief Executive OfficerMar 18 '26Sale25.009,725243,125571,725Mar 20 06:24 PM
Rogers CampbellOfficerMar 19 '26Proposed Sale25.6964,5331,658,030Mar 19 04:23 PM
Farquhar John C.M.OfficerMar 18 '26Proposed Sale25.009,725243,125Mar 18 02:17 PM
BARABE TIMOTHY CDirectorMar 11 '26Option Exercise2.228,66719,241179,521Mar 12 07:57 PM
Farquhar John C.M.Chief Executive OfficerMar 10 '26Sale22.6612,837290,886581,450Mar 12 07:55 PM
Farquhar John C.M.OfficerMar 10 '26Proposed Sale22.6612,837290,886Mar 10 10:53 AM
Cullivan Julie ADirectorMar 05 '26Sale25.009,122228,05027,291Mar 06 08:18 PM
Cullivan Julie ADirectorMar 05 '26Proposed Sale25.009,122228,050Mar 05 02:11 PM
BARABE TIMOTHY CDirectorFeb 17 '26Option Exercise8.332,49720,800170,854Feb 19 07:14 PM
Rogers CampbellChief Medical OfficerFeb 12 '26Option Exercise5.8467,016391,398141,187Feb 17 08:07 PM
Rogers CampbellChief Medical OfficerFeb 12 '26Sale24.4965,1531,595,48676,034Feb 17 08:07 PM
Rogers CampbellOfficerFeb 12 '26Proposed Sale24.4965,1531,595,485Feb 12 04:45 PM
Farquhar John C.M.Chief Executive OfficerFeb 10 '26Sale27.4622,562619,553591,656Feb 10 08:24 PM
Farquhar John C.M.OfficerFeb 10 '26Proposed Sale27.4622,562619,557Feb 10 04:12 PM
Cullivan Julie ADirectorFeb 05 '26Sale27.328,000218,56036,413Feb 06 09:42 PM
Bain Capital Life Sciences Inv10% OwnerFeb 04 '26Sale28.052,000,00056,100,00010,448,158Feb 06 04:58 PM
Cullivan Julie ADirectorFeb 05 '26Proposed Sale27.328,000218,560Feb 05 09:58 AM
Lightcap Jeffrey CDirectorDec 16 '25Buy26.3440,0001,053,68040,000Dec 17 06:43 PM